Trial Profile
A study assessing foralumab in subjects with graft-versus-host disease.
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Foralumab (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 25 May 2016 New trial record